(Q40321417)

19 September 2017

A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth (English)

1 reference

19 September 2017

1 reference

1 reference

6

1 reference

19 September 2017

Junan Li

1

1 reference

19 September 2017

Jiuxiang Zhu

2

1 reference

19 September 2017

W Scott Melvin

3

1 reference

19 September 2017

Tanios S Bekaii-Saab

4

1 reference

19 September 2017

Ching-Shih Chen

5

1 reference

19 September 2017

1 February 2006

1 reference

Journal of Gastrointestinal Surgery

19 September 2017

1 reference

19 September 2017

10

1 reference

19 September 2017

2

1 reference

19 September 2017

207-214

1 reference

https://scigraph.springernature.com/pub.10.1016/j.gassur.2005.07.025

19 September 2017

0 references

cites work

Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.

1 reference

12 December 2020

Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer

1 reference

12 December 2020

Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death

1 reference

12 December 2020

Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo

1 reference

12 December 2020

Cancer statistics, 2003.

1 reference

12 December 2020

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

12 December 2020

Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine

1 reference

12 December 2020

Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine

1 reference

12 December 2020

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

12 December 2020

Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells

1 reference

12 December 2020

Frequent activation of AKT2 kinase in human pancreatic carcinomas

1 reference

12 December 2020

Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics

1 reference

12 December 2020

Chemotherapy in advanced pancreatic adenocarcinoma

1 reference

12 December 2020

Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells

1 reference

12 December 2020

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer

1 reference

12 December 2020

The genetics of pancreatic cancer.

1 reference

12 December 2020

Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.

1 reference

12 December 2020

Inhibition of the phosphatidylinositol 3'-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac

1 reference

12 December 2020

From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors

1 reference

12 December 2020

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

1 reference

12 December 2020

3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells

1 reference

12 December 2020

The phosphoinositide 3-kinase pathway

1 reference

12 December 2020

5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells

1 reference

12 December 2020

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

12 December 2020

Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells

1 reference

12 December 2020

Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma

1 reference

12 December 2020

10.1016/J.GASSUR.2005.07.025

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference